Trimethadione
From Wikipedia, the free encyclopedia
Trimethadione
|
|
Systematic (IUPAC) name | |
3,5,5-trimethyl-1,3-oxazolidine-2,4-dione | |
Identifiers | |
CAS number | |
ATC code | N03 |
PubChem | |
DrugBank | |
Chemical data | |
Formula | C6H9NO3 |
Mol. mass | 143.141 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
X |
Legal status |
℞ Prescription only |
Routes | ? |
Trimethadione is an oxazolidinedione anticonvulsant. It is used to treat epileptic conditions that are resistant to other treatments; recent studies by Doctor Jianxin Bao, Ph.D., at Washington University in Saint Louis's Central Institute For The Deaf's Center For Presbyacusis and Aging suggest that trimethadione, along with other oxazolidinedione anticonvulsant medications may be useful in treating sensorineural hearing loss cases like those of Iraq war veterans- if the drug's side effects, like dizziness, can be lessened by modifying the drug so it does not cross into the brain itself.
[edit] Fetal trimethadione syndrome
If administered during pregnancy, fetal trimethadione syndrome may result causing Facial Dysmorphism(short upturned nose,slanted eyebrows), cardiac defects,Intra Uterine Growth Retardation,mental retardation. The fetal loss rate while using trimethadione has been reported to be as high as 87%.[1]
[edit] References
- ^ Teratology and Drug Use During Pregnancy Retrieved January 2007